Pharming Group(FRA) PHGN

Market Cap€696.46M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€0.98

-0.65%

-0.01Today

Pharming Group Financials at a Glance

Market Cap

€696.46M

Revenue (TTM)

€314.26

Net Income (TTM)

€7.89

EPS (TTM)

€0.01

P/E Ratio

86.32

Dividend

€0.00

Beta (Volatility)

0.12 (Low)

Dividend

€0.00

Beta (Volatility)

0.12 (Low)

Price

€0.98

Volume

Open

€0.98

Price

€0.98

Volume

Open

€0.98

Previous Close

€0.98

Daily Range

€0.98 - €0.98

52-Week Range

€0.87 - €1.76

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.12 (Low)

Price

€0.98

Volume

Open

€0.98

Previous Close

€0.98

Daily Range

€0.98 - €0.98

52-Week Range

€0.87 - €1.76

Estimated Earnings Date

N/A

PHGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharming Group

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.

Industry

Biotechnology

Sector

Health Care

CEO

Fabrice Chouraqui, MBA

Website

www.pharming.com

PHGN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.77%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.16%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€696.46M

Shares Outstanding

707.78M

Volume

Avg. Volume

1.59K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Pharming Group Performance Analysis

Pharming Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 195,648,930	16.3%
2023	2023-12-31	EUR 226,910,054	16.0%
2024	2024-12-31	EUR 274,755,052	21.1%
2025	2025-12-31	EUR 333,281,365	21.3%

Pharming Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.02	-4.7%
2023	2023-12-31	EUR -0.01	N/A
2024	2024-12-31	EUR -0.02	10.1%
2025	2025-12-31	EUR 0.00	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€77.58

+0.9%

Gross Profit

€62.49

+0.8%

Gross Margin

80.56%

+0.9%

Market Cap

€696.46M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

€1.38

+0.3%

EBITDA

€4.33

+0.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€249.31

+24.3%

Total Debt

€110.87

+0.9%

Accounts Receivable

€49.84

+1.1%

Inventory

€57.23

+1.1%

Long Term Debt

€102.95

+0.9%

Short Term Debt

€7.91

+1.0%

Return on Assets

2.00%

-1.0%

Return on Invested Capital

53.64%

+0.2%

Free Cash Flow

-€10.93

-1.0%

Operating Cash Flow

-€10.85

-1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

SNAPSnap

SNAPSnap$5.55+0.02%

Questions About PHGN

What is the current price of Pharming Group?

Pharming Group is trading at €0.98 per share.

What is the 52-week range for Pharming Group?

Over the past 52 weeks, Pharming Group has traded between €0.87 and €1.76.

How much debt does Pharming Group have?

As of the most recent reporting period, Pharming Group reported total debt of €110.87M.

How much cash does Pharming Group have on hand?

Pharming Group reported €138.44M in cash and cash equivalents in its most recent financial results.

What is Pharming Group’s dividend yield?

Pharming Group does not currently have a dividend yield.

Pharming Group(FRA) PHGN

Pharming Group Financials at a Glance

PHGN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pharming Group

PHGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pharming Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PHGN

What is the current price of Pharming Group?

What is the 52-week range for Pharming Group?

How much debt does Pharming Group have?

How much cash does Pharming Group have on hand?

What is Pharming Group’s dividend yield?

Premium Investing Services